Financials Procter & Gamble Company

Equities

PG

US7427181091

Personal Products

Real-time Estimate Cboe BZX 01:59:05 2024-12-13 pm EST 5-day change 1st Jan Change
171.16 USD +0.18% Intraday chart for Procter & Gamble Company -1.51% +16.82%

Projected Income Statement: Procter & Gamble Company

Forecast Balance Sheet: Procter & Gamble Company

balance-sheet-analysis-chart PROCTER-GAMBLE-COMPANY
Fiscal Period: Juni 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 18,539 21,700 24,279 26,361 22,978 22,723 19,474 19,070
Change - 17.05% 11.88% 8.58% -12.83% -1.11% -14.3% -2.07%
Announcement Date 7/30/20 7/30/21 7/29/22 7/28/23 7/30/24 - - -
1USD in Million
Estimates

Cash Flow Forecast: Procter & Gamble Company

Fiscal Period: Juni 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 3,073 2,787 3,156 3,062 3,322 3,725 3,761 3,933
Change - -9.31% 13.24% -2.98% 8.49% 12.14% 0.96% 4.57%
Free Cash Flow (FCF) 1 14,330 15,584 13,567 13,786 16,524 16,724 17,628 18,507
Change - 8.75% -12.94% 1.61% 19.86% 1.21% 5.4% 4.99%
Announcement Date 7/30/20 7/30/21 7/29/22 7/28/23 7/30/24 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Procter & Gamble Company

Fiscal Period: Juni 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 27% 27.22% 25.71% 25.42% 27.23% 28.24% 28.84% 29.53%
EBIT Margin (%) 22.75% 23.63% 22.21% 22.11% 23.78% 24.72% 25.35% 25.96%
EBT Margin (%) 22.32% 23.14% 22.44% 22.38% 22.32% 24.57% 25.5% 26.01%
Net margin (%) 18.36% 18.79% 18.38% 17.87% 17.7% 19.35% 20.2% 20.63%
FCF margin (%) 20.2% 20.47% 16.92% 16.81% 19.66% 19.51% 19.84% 20.07%
FCF / Net Income (%) 110% 108.93% 92.03% 94.08% 111.06% 100.81% 98.24% 97.28%

Profitability

        
ROA 11.05% 11.92% 12.47% 12.31% 13.39% 13.56% 14.18% 14.54%
ROE 27.58% 30.59% 31.53% 31.2% 30.48% 32.35% 32.16% 32.6%

Financial Health

        
Leverage (Debt/EBITDA) 0.97x 1.05x 1.18x 1.26x 1x 0.94x 0.76x 0.7x
Debt / Free cash flow 1.29x 1.39x 1.79x 1.91x 1.39x 1.36x 1.1x 1.03x

Capital Intensity

        
CAPEX / Current Assets (%) 4.33% 3.66% 3.94% 3.73% 3.95% 4.35% 4.23% 4.26%
CAPEX / EBITDA (%) 16.04% 13.45% 15.31% 14.69% 14.52% 15.39% 14.68% 14.44%
CAPEX / FCF (%) 21.44% 17.88% 23.26% 22.21% 20.1% 22.28% 21.33% 21.25%

Items per share

        
Cash flow per share 1 6.628 7.063 6.586 6.783 8.029 7.706 8.821 9.585
Change - 6.57% -6.75% 2.99% 18.37% -4.02% 14.47% 8.67%
Dividend per Share 1 3.028 3.242 3.523 3.681 3.829 4.009 4.166 4.374
Change - 7.05% 8.67% 4.47% 4.02% 4.72% 3.9% 5%
Book Value Per Share 1 18.91 19.2 19.57 19.8 20.45 22.33 24.68 26.29
Change - 1.54% 1.93% 1.18% 3.28% 9.16% 10.55% 6.52%
EPS 1 4.96 5.5 5.81 5.9 6.02 6.785 7.398 7.914
Change - 10.89% 5.64% 1.55% 2.03% 12.71% 9.03% 6.97%
Nbr of stocks (in thousands) 2,475,643 2,448,233 2,399,297 2,356,969 2,360,135 2,355,042 2,355,042 2,355,042
Announcement Date 7/30/20 7/30/21 7/29/22 7/28/23 7/30/24 - - -
1USD
Estimates
2025 *2026 *
P/E ratio 25.2x 23.1x
PBR 7.65x 6.92x
EV / Sales 4.96x 4.75x
Yield 2.35% 2.44%
More valuation ratios * Estimated data

EPS & Dividend

eps-dividend-chart PROCTER-GAMBLE-COMPANY

Year-on-year evolution of the PER

evolution-chart PROCTER-GAMBLE-COMPANY

Year-on-year evolution of the Yield

evolution-chart PROCTER-GAMBLE-COMPANY
Trading Rating
Investor Rating
ESG Refinitiv
C-
surperformance-ratings-light-chart PROCTER-GAMBLE-COMPANYMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
170.85USD
Average target price
180.88USD
Spread / Average Target
+5.87%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. PG Stock
  4. Financials Procter & Gamble Company